Back to Search
Start Over
Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO[TM] (ixazomib) in Multiple Myeloma as a First-Line Maintenance Therapy
- Source :
- Business Wire. June 12, 2020
- Publication Year :
- 2020
-
Abstract
- Positive Phase 3 Data Evaluating NINLARO as a Maintenance Therapy (TOURMALINE-MM4) Shows Significant Improvement in Progression-Free Survival in Adult Patients Not Treated with Stem Cell Transplantation Real-World Community-Based Trial (US [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.626427681